Trials / Completed
CompletedNCT01109485
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 7 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to further evaluate the safety of Olopatadine Ophthalmic Solution 0.1% in Japanese children with allergic conjunctivitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olopatadine hydrochloride ophthalmic solution 0.1% | 1-2 drops 4 times per day |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2010-04-23
- Last updated
- 2015-05-12
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01109485. Inclusion in this directory is not an endorsement.